QA: Globeimmune INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001245104_2015_Globeimmune_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001245104, Globeimmune INC

  xvar xval
0 AssetsCurrent 17,812,351
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 455,768
3 remainder_Assets 100,000
4 LiabilitiesCurrent 5,172,489
5 LiabilitiesNoncurrent 148,641
6 remainder_Liabilities 7,443,498
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,276,918
9 ResearchAndDevelopmentExpense 7,213,416
10 remainder_Expenses 4,185,827
11 remainder_Revenues 6,006,330
12 remainder_NetIncome -6,591,095
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 18,368,119
1 Liabilities 12,764,628
2 Expenses 15,676,161
3 Revenues 6,006,330
4 StockholdersEquity 5,603,491
5 NetIncome -16,260,926
6 ComprehensiveNetIncome -16,260,926
7 BaseVar 29,703,166
8 EconomicCapitalRatiobeforeLimitedLiability -0.260
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution